Literature DB >> 33420549

Increasing whole-body energetic stress does not augment fasting-induced changes in human skeletal muscle.

Hashim Islam1, Alessandra Amato1, Jacob T Bonafiglia1, Fasih A Rahman2, Nicholas Preobrazenski1, Andrew Ma2, Craig A Simpson1, Joe Quadrilatero2, Brendon J Gurd3.   

Abstract

Fasting rapidly (≤ 6 h) activates mitochondrial biogenic pathways in rodent muscle, an effect that is absent in human muscle following prolonged (10-72 h) fasting. We tested the hypotheses that fasting-induced changes in human muscle occur shortly after food withdrawal and are modulated by whole-body energetic stress. Vastus lateralis biopsies were obtained from ten healthy males before, during (4 h), and after (8 h) two supervised fasts performed with (FAST+EX) or without (FAST) 2 h of arm ergometer exercise (~ 400 kcal of added energy expenditure). PGC-1α mRNA (primary outcome measure) was non-significantly reduced (p = 0.065 [ηp2 = 0.14]) whereas PGC-1α protein decreased (main effect of time: p < 0.01) during both FAST and FAST+EX. P53 acetylation increased in both conditions (main effect of time: p < 0.01) whereas ACC and SIRT1 phosphorylation were non-significantly decreased (both p < 0.06 [ηp2 = 0.15]). Fasting-induced increases in NFE2L2 and NRF1 protein were observed (main effects of time: p < 0.03), though TFAM and COXIV protein remained unchanged (p > 0.05). Elevating whole-body energetic stress blunted the increase in p53 mRNA, which was apparent during FAST only (condition × time interaction: p = 0.04). Select autophagy/mitophagy regulators (LC3BI, LC3BII, BNIP3) were non-significantly reduced at the protein level (p ≤ 0.09 [ηp2 > 0.13]) but the LC3II:I ratio was unchanged (p > 0.05). PDK4 mRNA (p < 0.01) and intramuscular triglyceride content in type IIA fibers (p = 0.04) increased similarly during both conditions. Taken together, human skeletal muscle signaling, mRNA/protein expression, and substrate storage appear to be unaffected by whole-body energetic stress during the initial hours of fasting.

Entities:  

Keywords:  AMPK; Caloric restriction; Food deprivation; Metabolic flexibility; PGC-1α; SIRT1

Mesh:

Substances:

Year:  2021        PMID: 33420549     DOI: 10.1007/s00424-020-02499-7

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  46 in total

1.  AMPK activation of muscle autophagy prevents fasting-induced hypoglycemia and myopathy during aging.

Authors:  Adam L Bujak; Justin D Crane; James S Lally; Rebecca J Ford; Sally J Kang; Irena A Rebalka; Alex E Green; Bruce E Kemp; Thomas J Hawke; Jonathan D Schertzer; Gregory R Steinberg
Journal:  Cell Metab       Date:  2015-06-02       Impact factor: 27.287

2.  Differential regulation of lipid and protein metabolism in obese vs. lean subjects before and after a 72-h fast.

Authors:  Ann Mosegaard Bak; Andreas Buch Møller; Mikkel Holm Vendelbo; Thomas Svava Nielsen; Rikke Viggers; Jørgen Rungby; Steen Bønløkke Pedersen; Jens Otto Lunde Jørgensen; Niels Jessen; Niels Møller
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-05-31       Impact factor: 4.310

3.  Predominant alpha2/beta2/gamma3 AMPK activation during exercise in human skeletal muscle.

Authors:  J B Birk; J F P Wojtaszewski
Journal:  J Physiol       Date:  2006-10-12       Impact factor: 5.182

4.  Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle.

Authors:  Carles Cantó; Lake Q Jiang; Atul S Deshmukh; Chikage Mataki; Agnes Coste; Marie Lagouge; Juleen R Zierath; Johan Auwerx
Journal:  Cell Metab       Date:  2010-03-03       Impact factor: 27.287

Review 5.  PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure.

Authors:  Carles Cantó; Johan Auwerx
Journal:  Curr Opin Lipidol       Date:  2009-04       Impact factor: 4.776

6.  AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity.

Authors:  Carles Cantó; Zachary Gerhart-Hines; Jerome N Feige; Marie Lagouge; Lilia Noriega; Jill C Milne; Peter J Elliott; Pere Puigserver; Johan Auwerx
Journal:  Nature       Date:  2009-04-23       Impact factor: 49.962

7.  p53 orchestrates the PGC-1α-mediated antioxidant response upon mild redox and metabolic imbalance.

Authors:  Katia Aquilano; Sara Baldelli; Beatrice Pagliei; Stefano M Cannata; Giuseppe Rotilio; Maria R Ciriolo
Journal:  Antioxid Redox Signal       Date:  2012-09-20       Impact factor: 8.401

8.  PPARα-LXR as a novel metabolostatic signalling axis in skeletal muscle that acts to optimize substrate selection in response to nutrient status.

Authors:  Paul W Caton; Mark J Holness; David Bishop-Bailey; Mary C Sugden
Journal:  Biochem J       Date:  2011-08-01       Impact factor: 3.857

9.  Rapid determination of myosin heavy chain expression in rat, mouse, and human skeletal muscle using multicolor immunofluorescence analysis.

Authors:  Darin Bloemberg; Joe Quadrilatero
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

10.  Prolonged fasting-induced metabolic signatures in human skeletal muscle of lean and obese men.

Authors:  Ann Mosegaard Bak; Mikkel Holm Vendelbo; Britt Christensen; Rikke Viggers; Bo Martin Bibby; Jørgen Rungby; Jens Otto Lunde Jørgensen; Niels Møller; Niels Jessen
Journal:  PLoS One       Date:  2018-09-05       Impact factor: 3.240

View more
  2 in total

1.  LncRNA TP53TG1 plays an anti-oncogenic role in cervical cancer by synthetically regulating transcriptome profile in HeLa cells.

Authors:  Yi Cheng; Nan Huang; Qingqing Yin; Chao Cheng; Dong Chen; Chen Gong; Huihua Xiong; Jing Zhao; Jianhua Wang; Xiaoyu Li; Jing Zhang; Shuangshuang Mao; Kai Qin
Journal:  Front Genet       Date:  2022-10-04       Impact factor: 4.772

Review 2.  The impact of diet upon mitochondrial physiology (Review).

Authors:  Ioannis D Kyriazis; Eleni Vassi; Maria Alvanou; Christos Angelakis; Zoi Skaperda; Fotios Tekos; Venkata Naga Srikanth Garikipati; Demetrios A Spandidos; Demetrios Kouretas
Journal:  Int J Mol Med       Date:  2022-09-21       Impact factor: 5.314

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.